Interleukin-5 Antagonists [MoA] class drugs

2 results
  • cinqair - reslizumab injection, solution, concentrate

    (Reslizumab)
    Teva Respiratory, Llc
    Cinqair is an add-on maintenance treatment for adults 18+ with severe asthma and an eosinophilic phenotype. It is not for other eosinophilic conditions or relief of acute bronchospasm.
  • nucala - mepolizumab injection, powder, for solution

    (Mepolizumab)
    Glaxosmithkline Llc
    Nucala treats severe eosinophilic asthma (age 6+), chronic rhinosinusitis with nasal polyps (adults), eosinophilic COPD (adults), eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (age 12+). Not for acute bronchospasm.